Literature DB >> 30014362

3D myocardial deformation analysis from cine MRI as a marker of amyloid protein burden in cardiac amyloidosis: validation versus T1 mapping.

Na'ama Avitzur1, Alessandro Satriano1, Muhammad Afzal1, Mariam Narous1, Yoko Mikami1, Reis Hansen1, Gary Dobko1, Jacqueline Flewitt1, Carmen P Lydell1,2, Andrew G Howarth1,3, Kelvin Chow4, Nowell M Fine1,3, James A White5,6.   

Abstract

Cardiac amyloidosis (CA) is a significant contributor to heart failure with preserved ejection fraction and is appreciating expanding therapeutic options. Non-invasive tools aimed at accurate identification and surveillance of therapeutic response are of immediate and expanding need. While native and post-contrast T1 mapping quantify expansion of the extra-cellular compartment from amyloid protein deposition, 3D strain analysis of non-contrast cine images offers unique advantages relevant to high prevalence of renal insufficiency in this population and reduced dependency on field strength, pulse sequence, and vendor implementation. We aimed to evaluate global and segmental associations between 3D strain and T1 mapping in patients with cardiac amyloidosis. Twenty consecutive patients with confirmed CA were recruited and underwent a standardized cardiovascular magnetic resonance imaging protocol at 3 T including using multi-planar cine imaging and T1 mapping using a shortened modified look-locker inversion recovery sequence. T1 mapping was performed pre- and (when permitted by renal function) post-contrast and measured for segmental T1 values. Spatially-matched 3D strain-based measures were similarly calculated. Mean left ventricular ejection fraction was 61 ± 21% (range 30-73%). Mean global native T1 was 1308 ± 96 ms. Post-contrast T1 and partition coefficient were 558 ± 104 ms and 0.85 ± 0.31, respectively. Global myocardial strain values were 8.1 ± 2.9% in the longitudinal direction, - 9.2 ± 3.4% in the circumferential direction, and 41.7 ± 22.8% in the maximum principal direction. Segmental analyses confirmed relative worsening in T1 values and reductions in strain values in the basal myocardial segments with relative sparing of the apical segments. Significant associations between T1 and strain-based measures were observed globally and segmentally, with the strongest associations found both globally and segmentally in the circumferential and minimum principal directions of deformation. This study identifies strong associations between 3D myocardial strain and T1-mapping based markers of regional amyloid protein deposition. These findings support expanded investigation of myocardial strain as a surrogate marker of response to novel therapeutic strategies in patients with cardiac amyloidosis.

Entities:  

Keywords:  Cardiac amyloidosis; Cardiovascular magnetic resonance imaging; Late gadolinium enhancement; Myocardial strain; Native T1

Mesh:

Year:  2018        PMID: 30014362     DOI: 10.1007/s10554-018-1410-5

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  32 in total

1.  T1 mapping and amyloid cardiomyopathy: how much better can it get?

Authors:  Theodoros D Karamitsos; Stefan Neubauer
Journal:  Eur Heart J       Date:  2014-11-16       Impact factor: 29.983

2.  Alterations in regional myocardial deformation assessed by strain imaging in cardiac amyloidosis.

Authors:  Queenie Lo; Brian Haluska; Ee-May Chia; Ming-Wei Lin; David Richards; Thomas Marwick; Liza Thomas
Journal:  Echocardiography       Date:  2016-09-07       Impact factor: 1.724

3.  First-in-Human Phase I/II Study of NEOD001 in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction.

Authors:  Morie A Gertz; Heather Landau; Raymond L Comenzo; David Seldin; Brendan Weiss; Jeffrey Zonder; Giampaolo Merlini; Stefan Schönland; Jackie Walling; Gene G Kinney; Martin Koller; Dale B Schenk; Spencer D Guthrie; Michaela Liedtke
Journal:  J Clin Oncol       Date:  2016-02-08       Impact factor: 44.544

4.  Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis.

Authors:  David F Hutt; Anne-Marie Quigley; Joanne Page; Margaret L Hall; Maria Burniston; Dorothea Gopaul; Thirusha Lane; Carol J Whelan; Helen J Lachmann; Julian D Gillmore; Philip N Hawkins; Ashutosh D Wechalekar
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-06-16       Impact factor: 6.875

5.  Quantification of myocardial blood flow and extracellular volumes using a bolus injection of Gd-DTPA: kinetic modeling in canine ischemic disease.

Authors:  L D Diesbourg; F S Prato; G Wisenberg; D J Drost; T P Marshall; S E Carroll; B O'Neill
Journal:  Magn Reson Med       Date:  1992-02       Impact factor: 4.668

Review 6.  Wild-Type Transthyretin Cardiac Amyloidosis: Novel Insights From Advanced Imaging.

Authors:  David L Narotsky; Adam Castano; Jonathan W Weinsaft; Sabahat Bokhari; Mathew S Maurer
Journal:  Can J Cardiol       Date:  2016-05-13       Impact factor: 5.223

7.  Cardiovascular magnetic resonance myocardial feature tracking for quantitative viability assessment in ischemic cardiomyopathy.

Authors:  Andreas Schuster; Matthias Paul; Nuno Bettencourt; Geraint Morton; Amedeo Chiribiri; Masaki Ishida; Shazia Hussain; Roy Jogiya; Shelby Kutty; Boris Bigalke; Divaka Perera; Eike Nagel
Journal:  Int J Cardiol       Date:  2011-11-29       Impact factor: 4.164

8.  Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold.

Authors:  Stefan K Piechnik; Vanessa M Ferreira; Erica Dall'Armellina; Lowri E Cochlin; Andreas Greiser; Stefan Neubauer; Matthew D Robson
Journal:  J Cardiovasc Magn Reson       Date:  2010-11-19       Impact factor: 5.364

9.  Revisiting the risks of MRI with Gadolinium based contrast agents-review of literature and guidelines.

Authors:  Aurang Z Khawaja; Deirdre B Cassidy; Julien Al Shakarchi; Damian G McGrogan; Nicholas G Inston; Robert G Jones
Journal:  Insights Imaging       Date:  2015-08-08

10.  Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.

Authors:  Lynne K Williams; Julian F Forero; Zoran B Popovic; Dermot Phelan; Diego Delgado; Harry Rakowski; Bernd J Wintersperger; Paaladinesh Thavendiranathan
Journal:  J Cardiovasc Magn Reson       Date:  2017-08-07       Impact factor: 5.364

View more
  2 in total

Review 1.  Reference ranges ("normal values") for cardiovascular magnetic resonance (CMR) in adults and children: 2020 update.

Authors:  Nadine Kawel-Boehm; Scott J Hetzel; Bharath Ambale-Venkatesh; Gabriella Captur; Christopher J Francois; Michael Jerosch-Herold; Michael Salerno; Shawn D Teague; Emanuela Valsangiacomo-Buechel; Rob J van der Geest; David A Bluemke
Journal:  J Cardiovasc Magn Reson       Date:  2020-12-14       Impact factor: 5.364

Review 2.  Multimodality Imaging in the Evaluation and Prognostication of Cardiac Amyloidosis.

Authors:  Paul J Scheel; Monica Mukherjee; Allison G Hays; Joban Vaishnav
Journal:  Front Cardiovasc Med       Date:  2022-03-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.